BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $214,892 | -17.2% | 5,694 | 0.0% | 0.04% | -13.7% |
| Q2 2023 | $259,419 | +12.3% | 5,694 | 0.0% | 0.05% | +8.5% |
| Q1 2023 | $230,949 | +79537.6% | 5,694 | 0.0% | 0.05% | -24.2% |
| Q4 2022 | $290 | -99.9% | 5,694 | 0.0% | 0.06% | -10.1% |
| Q3 2022 | $307,000 | -16.1% | 5,694 | 0.0% | 0.07% | -11.5% |
| Q2 2022 | $366,000 | -17.2% | 5,694 | 0.0% | 0.08% | -9.3% |
| Q1 2022 | $442,000 | -9.6% | 5,694 | 0.0% | 0.09% | -10.4% |
| Q4 2021 | $489,000 | +6.8% | 5,694 | 0.0% | 0.10% | -5.0% |
| Q3 2021 | $458,000 | 0.0% | 5,694 | 0.0% | 0.10% | -7.3% |
| Q2 2021 | $458,000 | -4.6% | 5,694 | 0.0% | 0.11% | -11.4% |
| Q1 2021 | $480,000 | +5.0% | 5,694 | 0.0% | 0.12% | +3.4% |
| Q4 2020 | $457,000 | -0.2% | 5,694 | 0.0% | 0.12% | -19.6% |
| Q3 2020 | $458,000 | -6.5% | 5,694 | 0.0% | 0.15% | -11.9% |
| Q2 2020 | $490,000 | +6.1% | 5,694 | 0.0% | 0.17% | +11.3% |
| Q1 2020 | $462,000 | -2.9% | 5,694 | 0.0% | 0.15% | +20.8% |
| Q4 2019 | $476,000 | -4.4% | 5,694 | 0.0% | 0.12% | -9.4% |
| Q3 2019 | $498,000 | +5.7% | 5,694 | 0.0% | 0.14% | +11.3% |
| Q2 2019 | $471,000 | +1.7% | 5,694 | 0.0% | 0.12% | -3.1% |
| Q1 2019 | $463,000 | +23.5% | 5,694 | 0.0% | 0.13% | +11.3% |
| Q4 2018 | $375,000 | -14.6% | 5,694 | 0.0% | 0.12% | -0.9% |
| Q3 2018 | $439,000 | +4.5% | 5,694 | 0.0% | 0.12% | 0.0% |
| Q2 2018 | $420,000 | +13.5% | 5,694 | 0.0% | 0.12% | +3.6% |
| Q1 2018 | $370,000 | +0.5% | 5,694 | 0.0% | 0.11% | +1.8% |
| Q4 2017 | $368,000 | -84.7% | 5,694 | -63.6% | 0.11% | -86.5% |
| Q3 2017 | $2,410,000 | +598.6% | 15,640 | +174.7% | 0.82% | +604.3% |
| Q2 2017 | $345,000 | +16.9% | 5,694 | 0.0% | 0.12% | +13.7% |
| Q1 2017 | $295,000 | +17.1% | 5,694 | 0.0% | 0.10% | +5.2% |
| Q4 2016 | $252,000 | +7.7% | 5,694 | 0.0% | 0.10% | -14.2% |
| Q1 2016 | $234,000 | +2.2% | 5,694 | -5.0% | 0.11% | +2.7% |
| Q4 2015 | $229,000 | +22.5% | 5,994 | +5.3% | 0.11% | +18.3% |
| Q3 2015 | $187,000 | -76.5% | 5,694 | -50.0% | 0.09% | -76.6% |
| Q2 2015 | $796,000 | +104.1% | 11,388 | +100.0% | 0.40% | +109.5% |
| Q1 2015 | $390,000 | -6.7% | 5,694 | 0.0% | 0.19% | -13.2% |
| Q4 2014 | $418,000 | +2.0% | 5,694 | -0.4% | 0.22% | -4.4% |
| Q3 2014 | $410,000 | – | 5,714 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |